Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial. (2018)

First Author: 3C Study Collaborative Group


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 29226570

Publication URI:

Type: Journal Article/Review

Volume: 18

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 6

ISSN: 1600-6135